CHEMICAL MANAGEMENT

A META-ANALYSIS OF ROAD TRANSPORT EMISSIONS MODELS

May 22, 2022

A META-ANALYSIS
The authors thank Pramoda Gode, Joshua Miller of ICCT, Puneet Kamboj of CEEW,
Gerald Ollivier of the World Bank, and Pierpaolo Cazzola and Craglia Matteo, both of
ITF, for helpful reviews. Any errors are the authors’ own.

Spotlight

Acorda Therapeutics, Inc.

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions.

OTHER WHITEPAPERS
news image

A GREEN ALTERNATIVE TO TRADITIONAL PLASTICS

whitePaper | July 6, 2022

Plastics are found in a wide variety of products, ranging from grocery bags to car bumpers and are composed predominantly of synthetic polymers derived from petroleum.

Read More
news image

Development of Kinetic Models

whitePaper | August 26, 2022

safe storage, handling, and transportation of reactive chemicals is challenging. Characterization of both desired and undesired chemistries requires a variety

Read More
news image

Solutions for Ammonia Gas Detection: A Comparison Summary

whitePaper | October 21, 2022

The hazardous, toxic, and combustible nature of ammonia is wellknown in industrial settings. Undetected ammonia leaks in production

Read More
news image

Employee Scheduling for Manufacturing: A Best Practices Guide

whitePaper | June 16, 2021

As demand continues to surge for many chemical manufacturers, ensuring adequate staffing to meet daily volume targets is a top-of-mind issue for plant managers. Read the guide to discover the best practices of employee scheduling you can leverage to improve the overall effectiveness of labor resources

Read More
news image

Validation of Titration Methods

whitePaper | September 8, 2022

The quality of your product depends on the analyses performed in quality control. That is why you rely on first-rate analytical instruments for the most accurate and precise results, and product quality

Read More
news image

Cumulative Impacts Recommendations for ORD Research

whitePaper | January 15, 2022

This white paper was developed to inform the Office of Research and Development's (ORD) FY23-26 Strategic Research Action Plans (StRAPs) under development by the six national research programs.

Read More

Spotlight

Acorda Therapeutics, Inc.

Acorda Therapeutics is a publicly traded (NASDAQ: ACOR) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. We started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. We have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions.

Events